(Q45867414)

17 December 2017

title

Cascading towards vascular disorder gene therapy (English)

1 reference

17 December 2017

0 references

1

1 reference

17 December 2017

author name string

Rapp UR

series ordinal

2

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

17 December 2017

published in

Nature Medicine

1 reference

17 December 2017

volume

1

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

513-515

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/nm0695-513

exact match

0 references

cites work

The ins and outs of Raf kinases

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-513

Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-513

Thyrotropin-induced mitogenesis is Ras dependent but appears to bypass the Raf-dependent cytoplasmic kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-513

The MEK kinase activity of the catalytic domain of RAF-1 is regulated independently of Ras binding in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-513

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-513

Inhibition of phosphatidylinositol 4-phosphate kinase by heparin. A possible mechanism for the antiproliferative effects of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-513

Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-513

7 January 2021

Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-513

7 January 2021

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-513

7 January 2021

Gene therapy for vascular smooth muscle cell proliferation after arterial injury

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-513

7 January 2021

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-513

7 January 2021

Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-513

7 January 2021

Identifiers

DOI

10.1038/NM0695-513

1 reference

17 December 2017

Dimensions Publication ID

1003524102

0 references

1 reference

17 December 2017